Study Shows Cannabis Oil Improves Crohn’s Disease Symptoms

A new study shows that cannabis oil can improve the symptoms of Crohn’s disease – an inflammatory bowel disease that causes severe stomach pain and chronic diarrhea. The study was led by Dr. Timna Naftali, an Israeli gastroenterologist who also…

More Americans Favor Marijuana Legalization

A recent Pew Research Center survey shows that 62% of Americans favor the legalization of marijuana – that’s six out of 10 Americans. The percentage is twice what it was in the year 2000, when only 31% of Americans said…

California Approves Equity Program for Cannabis

The governor of California, Jerry Brown, recently signed legislation that aids small cannabis businesses and low-income individuals. It’s called The California Cannabis Equity Act and lawmakers have allocated $10 million as initial funding for it. The bill’s aim is to…

Chemesis Enters Cannabis Beverage Market

Chemesis International Inc. says it will enter the cannabis-infused beverage market soon. The company will leverage its licenses and assets to build a production, storage, and transport network for its cannabis-infused beverages. Reports suggest that cannabis is a lucrative industry:…

DEA Reschedules Cannabis-Derived Drug

The Drug Enforcement Agency (DEA) recently classified GW Pharmaceutical’s drug Epidiolex as Schedule V from Schedule I. This means that doctors can legally prescribe Epidiolex (a marijuana-derived medication) in the United States. It is the first marijuana-derived drug to achieve…

Cannabis Beverage Market to Hit $400M by 2022

Canaccord Genuity predicts that cannabis-infused beverages could become a $600 million market in the United States (US) by 2022. That’s why beverage giants like Coca-Cola are looking to enter the market. The analysts from Canaccord say that cannabidiol (CBD) beverages…

SUBSCRIBE & GET THE LATEST CHEMESIS STOCK ALERTS

SUBSCRIBE & GET THE LATEST CHEMESIS STOCK ALERTS